Amit Sachdev

CIK 1406338 · EVP Chief Patient & Ext Af Off · last filed 2026-02-26

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$28.86M

Companies

2

Total Filings

146

Lifetime Open-Market Net

-$171.36M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
VRTX EVP Chief Patient & Ext Af Off 64,871 $444.93 $28.86M -$171.36M 141 2026-02-26
Eiger BioPharmaceuticals, Inc. (EIGR) Delisted Director 16,000 $1.73 $27.6K $0 5 2023-03-03

Recent Filings · Page 2 of 15

146 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-02-12 VRTX Tax (F) −2,056 -$962.2K EDGAR
2025-02-06 VRTX Grant (A) +15,324 $0 EDGAR
2024-06-07 VRTX Gift (G) −4,600 $0 EDGAR
2024-05-17 VRTX Sell (S) −32 -$13.8K EDGAR
2024-02-27 VRTX Mixed −5,473 -$2.34M EDGAR
2024-02-23 VRTX Sell (S) −3,191 -$1.35M EDGAR
2024-02-21 VRTX Mixed −10,375 -$4.38M EDGAR
2024-02-13 VRTX Mixed −5,244 -$2.21M EDGAR
2024-02-08 VRTX Grant (A) +20,794 $0 EDGAR
2023-11-17 VRTX Sell (S) −35 -$12.9K EDGAR
Showing 1120 of 146
Page 2 of 15
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.